Eric K. Waller, Ph.D. - Publications

Affiliations: 
2014 Environmental Science, Policy, and Management University of California, Berkeley, Berkeley, CA 
Area:
Environmental Sciences, Ecology Biology, Remote Sensing

205 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, ... ... Waller EK, et al. Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27040394 DOI: 10.1016/j.bbmt.2016.03.018  0.36
2015 Jagirdar N, Harvey RD, Nooka A, Flowers C, Kaufman J, Lonial S, Lechowicz MJ, Langston A, Lipscomb C, Gaylor C, Waller EK. Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion. 55: 2351-7. PMID 26331348 DOI: 10.1111/trf.13186  0.36
2015 Hassan MN, Waller EK. GVHD clears the Aire in thymic selection Blood. 125: 2593-2595. PMID 25907903  0.36
2015 Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, Stempora L, Horan JT, Langston A, Qayed M, Khoury HJ, Grizzle A, Cheeseman JA, Conger JA, Robertson J, ... ... Waller EK, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 125: 3835-50. PMID 25852054 DOI: 10.1182/blood-2015-03-631853  0.36
2015 Napier RJ, Norris BA, Swimm A, Giver CR, Harris WA, Laval J, Napier BA, Patel G, Crump R, Peng Z, Bornmann W, Pulendran B, Buller RM, Weiss DS, Tirouvanziam R, ... Waller EK, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770. PMID 25822986 DOI: 10.1371/journal.ppat.1004770  0.36
2015 Hayek SS, Poole JC, Neuman R, Morris AA, Khayata M, Kavtaradze N, Topel ML, Binongo JG, Li Q, Jones DP, Waller EK, Quyyumi AA. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. Journal of the American Society of Hypertension : Jash. 9: 206-13. PMID 25681236 DOI: 10.1016/j.jash.2014.12.013  0.36
2015 Copland IB, Qayed M, Garcia MA, Galipeau J, Waller EK. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 934-40. PMID 25659882 DOI: 10.1016/j.bbmt.2015.01.014  0.36
2015 Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, ... ... Waller EK, et al. New cancers after autotransplantations for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 738-45. PMID 25555448 DOI: 10.1016/j.bbmt.2014.12.028  0.36
2015 Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, ... ... Waller EK, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 266-74. PMID 25445023 DOI: 10.1016/j.bbmt.2014.10.021  0.36
2015 Patel RS, Li Q, Ghasemzadeh N, Eapen DJ, Moss LD, Janjua AU, Manocha P, Al Kassem H, Veledar E, Samady H, Taylor WR, Zafari AM, Sperling L, Vaccarino V, Waller EK, et al. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. Circulation Research. 116: 289-97. PMID 25323857 DOI: 10.1161/CIRCRESAHA.116.304187  0.36
2015 Hosoba S, Jaye DL, Cohen C, Roback JD, Waller EK. Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature. Transfusion. 55: 259-64. PMID 25156334 DOI: 10.1111/trf.12815  0.36
2015 Long G, Waller EK, Gregurek S, Tricot G, Marschner S, Bill J. Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients. Journal of Clinical Apheresis. 30: 1-7. PMID 24941931 DOI: 10.1002/jca.21341  0.36
2015 Nastoupil LJ, Shenoy PJ, Ambinder A, Koff JL, Nooka AK, Waller EK, Langston A, Seward M, Kaufman JL, Bernal-Mizrachi L, King N, Lechowicz MJ, Lonial S, Sinha R, Flowers CR. Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & Lymphoma. 56: 383-9. PMID 24828864 DOI: 10.3109/10428194.2014.921296  0.36
2015 Hassan MN, Waller EK. Treating chemotherapy-induced thrombocytopenia: Is it timefor oncologists to use thrombopoietin agonists Oncology (United States). 29.  0.36
2014 Hosoba S, Harris WA, Lin KL, Waller EK. Chemokine and lymph node homing receptor expression on pDC vary by graft source. Oncoimmunology. 3: e958957. PMID 25941585 DOI: 10.4161/21624011.2014.958957  0.36
2014 Ghasemzadeh N, Zhang L, Al Mheid I, Li Q, Sperling L, Waller EK, Taylor WR, Guest J, Quyyumi AA, Mavromatis K. Circulating progenitor cells are reduced in HIV-positive, anti-retroviral naïve patients. International Journal of Cardiology. 176: 1150-2. PMID 25175523 DOI: 10.1016/j.ijcard.2014.07.282  0.36
2014 El Rassi F, Ward KC, Flowers CR, Heffner LT, Waller EK, Winton EF, Vaughn J, Hill BG, Langston A, Nooka A, Arellano M, Khoury HJ. Incidence and geographic distribution of adult acute leukemia in the state of Georgia. Southern Medical Journal. 107: 497-500. PMID 25084186 DOI: 10.14423/SMJ.0000000000000146  0.36
2014 Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood. 124: 1372-7. PMID 24982504 DOI: 10.1182/blood-2014-04-567164  0.36
2014 Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2365-72. PMID 24982459 DOI: 10.1200/JCO.2013.54.4577  0.36
2014 Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, ... ... Waller EK, et al. Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1. Bone Marrow Transplantation. 49: 1176-83. PMID 24955785 DOI: 10.1038/bmt.2014.122  0.36
2014 Hossain MS, Ramachandiran S, Gewirtz AT, Waller EK. Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice. Plos One. 9: e96165. PMID 24879439 DOI: 10.1371/journal.pone.0096165  0.36
2014 Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International Journal of Radiation Oncology, Biology, Physics. 89: 360-9. PMID 24837891 DOI: 10.1016/j.ijrobp.2014.02.032  0.36
2014 Al-Kadhimi Z, Gul Z, Chen W, Smith D, Abidi M, Deol A, Ayash L, Lum L, Waller EK, Ratanatharathorn V, Uberti J. High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 979-85. PMID 24709007 DOI: 10.1016/j.bbmt.2014.03.016  0.36
2014 Kaliyaperumal S, Watkins B, Sharma P, Furlan S, Ramakrishnan S, Giver C, Garcia A, Courtney C, Knight H, Strobert E, Elder E, Crenshaw T, Blazar BR, Waller EK, Westmoreland S, et al. CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis. Blood. 123: 1967-9. PMID 24652969 DOI: 10.1182/blood-2014-01-547612  0.36
2014 McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, ... ... Waller EK, et al. Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 960-8. PMID 24641829 DOI: 10.1016/j.bbmt.2014.03.013  0.36
2014 Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, ... ... Waller EK, et al. Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 951-9. PMID 24641828 DOI: 10.1016/j.bbmt.2014.03.014  0.36
2014 Roback JD, Josephson CD, Waller EK, Newman JL, Karatela S, Uppal K, Jones DP, Zimring JC, Dumont LJ. Metabolomics of ADSOL (AS-1) red blood cell storage. Transfusion Medicine Reviews. 28: 41-55. PMID 24636780 DOI: 10.1016/j.tmrv.2014.01.003  0.36
2014 Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A, Steuer C, Graiser M, Ali Z, Shah NN, Rangaraju S, Nickleach D, Gao J, Lonial S, Waller EK. Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 852-7. PMID 24607557 DOI: 10.1016/j.bbmt.2014.02.025  0.36
2014 Darlak KA, Wang Y, Li JM, Harris WA, Giver CR, Huang C, Waller EK. Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation. Journal of Hematology & Oncology. 7: 16. PMID 24580829 DOI: 10.1186/1756-8722-7-16  0.36
2014 Hosoba S, Waller EK. New molecule for mobilizing marrow stem cells Blood. 123: 310-311. PMID 24434996 DOI: 10.1182/blood-2013-12-538249  0.36
2014 Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe LA, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SG, Petersdorf EW, Schultz K, ... ... Waller EK, et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 123: 1270-8. PMID 24408320 DOI: 10.1182/blood-2013-10-532671  0.36
2014 Howard A, Chitphakdithai P, Waller EK, Harris W, Rosenthal H, Nelson W, Majhail N, Navarro W, Waldvogel S, Lisy J, Uecker J, Miller J, Spellman SR. Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services. Transfusion. 54: 1501-7. PMID 24383419 DOI: 10.1111/trf.12533  0.36
2014 Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, ... ... Waller EK, et al. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 273-81. PMID 24344210 DOI: 10.1200/JCO.2013.49.2454  0.36
2014 Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, et al. Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 202-8. PMID 24184335 DOI: 10.1016/j.bbmt.2013.10.023  0.36
2014 Langston AA, Prichard JM, Muppidi S, Nooka A, Lechowicz MJ, Lonial S, Sinha R, Graiser M, Kaufman JL, Khoury HJ, Flowers CR, Waller EK. Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone Marrow Transplantation. 49: 185-9. PMID 24162613 DOI: 10.1038/bmt.2013.168  0.36
2014 Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, et al. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 89-97. PMID 24161923 DOI: 10.1016/j.bbmt.2013.10.018  0.36
2014 Mitri Z, Siddiqui MT, El Rassi F, Holden JT, Heffner LT, Langston A, Waller EK, Winton E, McLemore M, Bernal-Mizrachi L, Jaye D, Arellano M, Khoury HJ. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leukemia & Lymphoma. 55: 1498-500. PMID 24134778 DOI: 10.3109/10428194.2013.852667  0.36
2014 Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, ... ... Waller EK, et al. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia. 28: 658-65. PMID 23989431 DOI: 10.1038/leu.2013.253  0.36
2013 Chinnadurai R, Waller EK, Galipeau J, Nooka AK. From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases. Biomed Research International. 2013: 929842. PMID 24350294 DOI: 10.1155/2013/929842  0.36
2013 Poole J, Mavromatis K, Binongo JN, Khan A, Li Q, Khayata M, Rocco E, Topel M, Zhang X, Brown C, Corriere MA, Murrow J, Sher S, Clement S, Ashraf K, ... ... Waller EK, et al. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial. Jama. 310: 2631-9. PMID 24247554 DOI: 10.1001/jama.2013.282540  0.36
2013 Armand P, Nagler A, Weller EA, Devine SM, Avigan DE, Chen YB, Kaminski MS, Holland HK, Winter JN, Mason JR, Fay JW, Rizzieri DA, Hosing CM, Ball ED, Uberti JP, ... ... Waller EK, et al. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4199-206. PMID 24127452 DOI: 10.1200/JCO.2012.48.3685  0.36
2013 Sinha R, Shenoy PJ, King N, Lechowicz MJ, Bumpers K, Hutcherson D, Arellano M, Langston A, Kaufman J, Heffner LT, Waller EK, Nooka A, Flowers CR, Lonial S. Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical Lymphoma, Myeloma & Leukemia. 13: 657-63. PMID 24094894 DOI: 10.1016/j.clml.2013.05.007  0.36
2013 Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, ... ... Waller EK, et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 122: 3863-70. PMID 24065243 DOI: 10.1182/blood-2013-07-514448  0.36
2013 Yun HD, Waller EK. Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia Blood. 122: 474. PMID 24049774 DOI: 10.1182/blood-2013-02-481697  0.36
2013 Koura DT, Horan JT, Langston AA, Qayed M, Mehta A, Khoury HJ, Harvey RD, Suessmuth Y, Couture C, Carr J, Grizzle A, Johnson HR, Cheeseman JA, Conger JA, Robertson J, ... ... Waller EK, et al. In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1638-49. PMID 24047754 DOI: 10.1016/j.bbmt.2013.09.003  0.36
2013 Nooka AK, Kaufman JL, Behera M, Langston A, Waller EK, Flowers CR, Gleason C, Boise LH, Lonial S. Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer. 119: 4119-28. PMID 24005889 DOI: 10.1002/cncr.28325  0.36
2013 Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, et al. Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1615-24. PMID 23939198 DOI: 10.1016/j.bbmt.2013.08.002  0.36
2013 Copland IB, Garcia MA, Waller EK, Roback JD, Galipeau J. The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. Biomaterials. 34: 7840-50. PMID 23891515 DOI: 10.1016/j.biomaterials.2013.06.050  0.36
2013 Forghani P, Harris W, Giver CR, Mirshafiey A, Galipeau J, Waller EK. Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice. Plos One. 8: e64837. PMID 23843936 DOI: 10.1371/journal.pone.0064837  0.36
2013 Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, ... ... Waller EK, et al. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. British Journal of Haematology. 162: 648-56. PMID 23829536 DOI: 10.1111/bjh.12451  0.36
2013 Darlak KA, Wang Y, Li JM, Harris WA, Owens LM, Waller EK. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1331-9. PMID 23810844 DOI: 10.1016/j.bbmt.2013.06.016  0.36
2013 Harvey RD, Kaufman JL, Johnson HR, Nooka A, Vaughn L, Flowers CR, Khoury HJ, Lechowicz MJ, Langston AA, Lonial S, Waller EK. Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1393-5. PMID 23764455 DOI: 10.1016/j.bbmt.2013.06.003  0.36
2013 Li JM, Darlak KA, Southerland L, Hossain MS, Jaye DL, Josephson CD, Rosenthal H, Waller EK. VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice. Plos One. 8: e63381. PMID 23723978 DOI: 10.1371/journal.pone.0063381  0.36
2013 Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, ... ... Waller EK, et al. Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1102-8. PMID 23632091 DOI: 10.1016/j.bbmt.2013.04.022  0.36
2013 Yun HD, Waller EK. Finding the sweet spot for donor lymphocyte infusions Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 507-508. PMID 23416853 DOI: 10.1016/j.bbmt.2013.02.005  0.36
2013 Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, et al. Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 741-5. PMID 23380341 DOI: 10.1016/j.bbmt.2013.01.020  0.36
2013 Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, et al. Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood. 121: 2567-73. PMID 23361908 DOI: 10.1182/blood-2012-08-453860  0.36
2013 Owonikoko TK, Hossain MS, Bhimani C, Chen Z, Kim S, Ramalingam SS, Sun SY, Shin DM, Waller EK, Khuri FR. Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer. 119: 1503-11. PMID 23340930 DOI: 10.1002/cncr.27937  0.36
2013 Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, ... ... Waller EK, et al. Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 625-31. PMID 23333532 DOI: 10.1016/j.bbmt.2013.01.009  0.36
2013 Li JM, Hossain MS, Southerland L, Waller EK. Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients. Blood. 121: 2347-51. PMID 23325838 DOI: 10.1182/blood-2012-06-437640  0.36
2013 Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 460-7. PMID 23201472 DOI: 10.1016/j.bbmt.2012.11.017  0.36
2013 Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 121: 197-206. PMID 23109243 DOI: 10.1182/blood-2012-03-417667  0.36
2013 Vose JM, Friedberg JW, Waller EK, Cheson BD, Juvvigunta V, Fritsch H, Petit C, Munzert G, Younes A. The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study. Leukemia & Lymphoma. 54: 708-13. PMID 22978685 DOI: 10.3109/10428194.2012.729833  0.36
2013 Bethelmie-Bryan B, Lord K, Holloway S, Safavi F, Shepard M, Rogers S, Harvey RD, Rodger K, Waller EK, El-Rayes B, Arellano M, Khoury HJ. Tools to optimize the functionality of a leukemia clinical trial team. Leukemia & Lymphoma. 54: 110-6. PMID 22762552 DOI: 10.3109/10428194.2012.708929  0.36
2013 Kaufman JL, Flowers CR, Rados KD, Calandra GB, Vose JM, Hewes LB, Lonial S, Langston AA, Khoury HJ, Lechowicz MJ, Waller EK. A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion. 53: 76-84. PMID 22624594 DOI: 10.1111/j.1537-2995.2012.03719.x  0.36
2012 Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Anasetti C, Weisdorf D, Miller JS. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. Journal of Immunology (Baltimore, Md. : 1950). 189: 5082-8. PMID 23077239 DOI: 10.4049/jimmunol.1201964  0.36
2012 Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. The New England Journal of Medicine. 367: 1487-96. PMID 23075175 DOI: 10.1056/NEJMoa1203517  0.36
2012 Bacher U, Klyuchnikov E, Le-Rademacher J, Carreras J, Armand P, Bishop MR, Bredeson CN, Cairo MS, Fenske TS, Freytes CO, Gale RP, Gibson J, Isola LM, Inwards DJ, Laport GG, ... ... Waller EK, et al. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Blood. 120: 4256-62. PMID 23007405 DOI: 10.1182/blood-2012-06-436725  0.36
2012 Mavromatis K, Sutcliffe DJ, Joseph G, Alexander RW, Waller EK, Quyyumi AA, Taylor WR. Proangiogenic cell colonies grown in vitro from human peripheral blood mononuclear cells. Journal of Biomolecular Screening. 17: 1128-35. PMID 22904201 DOI: 10.1177/1087057112457043  0.36
2012 Hamilton ES, Waller EK. Hematopoietic Progenitor Cell Apheresis processing Methods in Molecular Biology (Clifton, N.J.). 904: 97-109. PMID 22890926 DOI: 10.1007/978-1-61779-943-3_9  0.36
2012 Vaughn ML, Waller EK. Monitoring blood for CD34+ cells to determine timing of Hematopoietic Progenitor Cells Apheresis Methods in Molecular Biology (Clifton, N.J.). 904: 79-83. PMID 22890923 DOI: 10.1007/978-1-61779-943-3_6  0.36
2012 Jaye DL, Bray RA, Gebel HM, Harris WA, Waller EK. Translational applications of flow cytometry in clinical practice. Journal of Immunology (Baltimore, Md. : 1950). 188: 4715-9. PMID 22556132 DOI: 10.4049/jimmunol.1290017  0.36
2012 Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Pharmacokinetic-Directed High-Dose Busulfan Combined with Cyclophosphamide and Etoposide Results in Predictable Drug Levels and Durable Long-Term Survival in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 18: 1287-1294. PMID 22370160 DOI: 10.1016/j.bbmt.2012.02.006  0.36
2012 Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplantation. 47: 1350-5. PMID 22327131 DOI: 10.1038/bmt.2011.261  0.36
2012 Wang Y, Fan KT, Li JM, Waller EK. The regulation and activity of interleukin-12. Frontiers in Bioscience (Scholar Edition). 4: 888-99. PMID 22202097  0.36
2012 Forghani P, Khorramizadeh MR, Waller EK. Natural suppressor cells; Past, present and future Frontiers in Bioscience - Elite. 4: 1237-1245. PMID 22201949  0.36
2012 Weisdorf D, Cooley S, Devine S, Fehniger TA, DiPersio J, Anasetti C, Waller EK, Porter D, Farag S, Drobyski W, Defor T, Haagenson M, Curtsinger J, Miller J. T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 937-43. PMID 22155505 DOI: 10.1016/j.bbmt.2011.11.024  0.36
2012 Lu Y, Giver CR, Sharma A, Li JM, Darlak KA, Owens LM, Roback JD, Galipeau J, Waller EK. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity Blood. 119: 1075-1085. PMID 22130799 DOI: 10.1182/blood-2010-12-322891  0.36
2012 Giver CR, Jaye DL, Waller EK, Lonial S. Recovery and rebound of platelet counts in mice after thrombocytopenia induced by combination bortezomib + romidepsin. Experimental Hematology. 40: 95-6. PMID 22101254 DOI: 10.1016/j.exphem.2011.11.002  0.36
2012 François M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing Cytotherapy. 14: 147-152. PMID 22029655 DOI: 10.3109/14653249.2011.623691  0.36
2012 Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, et al. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 280-8. PMID 21810400 DOI: 10.1016/j.bbmt.2011.07.024  0.36
2012 Akhtari M, Waller EK. Neutropenias in Felty's syndrome and systemic lupus erythematosus Milestones in Drug Therapy. 43: 381-391. DOI: 10.1007/978-3-0348-0218-5_20  0.36
2011 Hossain MS, Jaye DL, Pollack BP, Farris AB, Tselanyane ML, David E, Roback JD, Gewirtz AT, Waller EK. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 5130-40. PMID 22013117 DOI: 10.4049/jimmunol.1101334  0.36
2011 Desmarets M, Mylvaganam G, Waller EK, Josephson CD, Pack C, Lukacher AE, Zimring JC. Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function American Journal of Transplantation. 11: 1825-1834. PMID 21884408 DOI: 10.1111/j.1600-6143.2011.03730.x  0.36
2011 Rauf M, Gleason C, Nooka AK, Husman A, Waller EK. Treatment of severe neutropenia with high-dose pyridoxine in a patient with chronic graft versus host disease and squamous cell carcinoma: a case report. Journal of Medical Case Reports. 5: 372. PMID 21838907 DOI: 10.1186/1752-1947-5-372  0.36
2011 Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, Weisdorf DJ, Miller JS. NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. Blood. 118: 2784-92. PMID 21757615 DOI: 10.1182/blood-2011-04-347070  0.36
2011 Murrow J, Esteves F, Galt J, Chen J, Garcia E, Lin J, Lerakis S, Sher S, Khan Pohlel F, Waller EK, Vaughan D, Perin E, Willerson J, Kereiakes D, Preti R, et al. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 18: 912-9. PMID 21717276 DOI: 10.1007/s12350-011-9414-8  0.36
2011 Li JM, Southerland L, Hossain MS, Giver CR, Wang Y, Darlak K, Harris W, Waschek J, Waller EK. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. Journal of Immunology (Baltimore, Md. : 1950). 187: 1057-65. PMID 21677142 DOI: 10.4049/jimmunol.1100686  0.36
2011 Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, Langston A, Prichard JM, Anderson D, Gleason C, Lonial S, Flowers CR, Kaufman JL, Waller EK. Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion. 51: 2175-82. PMID 21492180 DOI: 10.1111/j.1537-2995.2011.03136.x  0.36
2011 Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood. 117: 6963-70. PMID 21464372 DOI: 10.1182/blood-2011-01-332007  0.36
2011 Josephson CD, Castillejo MI, Caliendo AM, Waller EK, Zimring J, Easley KA, Kutner M, Hillyer CD, Roback JD. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfusion Medicine Reviews. 25: 125-32. PMID 21345642 DOI: 10.1016/j.tmrv.2010.11.004  0.36
2011 Renfroe H, Arnold M, Vaughn L, Harvey RD, Hamilton E, Lonial S, Khoury HJ, Kaufman JL, Lechowicz MJ, Flowers CR, Waller EK. A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation. Transfusion. 51: 1779-83. PMID 21332729 DOI: 10.1111/j.1537-2995.2010.03052.x  0.36
2011 Bouchentouf M, Forner K, Cuerquis J, Boulassel MR, Routy JP, Waller EK, Quyyumi AA, Paradis P, Schiffrin EL, Galipeau J. A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease Cell Transplantation. 20: 1431-1443. PMID 21294961 DOI: 10.3727/096368910X557164  0.36
2011 Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh BJ, Gregory D, Werner A, et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal. 161: 98-105. PMID 21167340 DOI: 10.1016/j.ahj.2010.09.025  0.36
2011 Giver CR, Jaye DL, Waller EK, Kaufman JL, Lonial S. Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes. Leukemia. 25: 362-5. PMID 21109772 DOI: 10.1038/leu.2010.262  0.36
2011 Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, ... ... Waller EK, et al. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1018-24. PMID 21034842 DOI: 10.1016/j.bbmt.2010.10.029  0.36
2011 Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, Marks DI, McCarthy PL, Oudshoorn M, Petersdorf EW, Ringdén O, Setterholm M, Spellman SR, Waller EK, Gajewski JL, et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 640-8. PMID 20674756 DOI: 10.1016/j.bbmt.2010.07.022  0.36
2011 August KJ, Chiang KY, Bostick RM, Flanders WD, Waller EK, Langston A, Worthington-White D, Rowland P, Moore KF, Khoury HJ, Horan JT. Biomarkers of immune activation to screen for severe, acute GVHD. Bone Marrow Transplantation. 46: 601-4. PMID 20622904 DOI: 10.1038/bmt.2010.165  0.36
2010 Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston AA, Heffner LT, Torre C, McMillan S, Renfroe H, Harvey RD, Lechowicz MJ, Khoury HJ, Flowers CR, Waller EK. A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5079-86. PMID 20739431 DOI: 10.1158/1078-0432.CCR-10-1662  0.36
2010 Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, ... Waller EK, et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 116: 1839-48. PMID 20538804 DOI: 10.1182/blood-2010-04-278317  0.36
2010 Akhtari M, Giver CR, Ali Z, Flowers CR, Gleason CL, Hillyer CD, Kaufman J, Khoury HJ, Langston AA, Lechowicz MJ, Lonial S, Renfroe HM, Roback JD, Tighiouart M, Vaughn L, ... Waller EK, et al. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion. 50: 2424-31. PMID 20529004 DOI: 10.1111/j.1537-2995.2010.02712.x  0.36
2010 McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, Dipersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, ... ... Waller EK, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1878-87. PMID 20212255 DOI: 10.1200/JCO.2009.25.4821  0.36
2009 Li JM, Giver CR, Lu Y, Hossain MS, Akhtari M, Waller EK. Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy. 1: 599-621. PMID 20191089 DOI: 10.2217/imt.09.32  0.36
2009 Li JM, Southerland LT, Lu Y, Darlak KA, Giver CR, McMillin DW, Harris WA, Jaye DL, Waller EK. Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation. Journal of Immunology (Baltimore, Md. : 1950). 183: 7799-809. PMID 19933853 DOI: 10.4049/jimmunol.0900155  0.36
2009 Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, Bevan MJ, Waller EK, Yu XZ, Beg AA. PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. The Journal of Clinical Investigation. 119: 3774-86. PMID 19907075 DOI: 10.1172/JCI39692  0.36
2009 Lu Y, Waller EK. Dichotomous role of interferon-γ in allogeneic bone marrow transplant Biology of Blood and Marrow Transplantation. 15: 1347-1353. PMID 19822293 DOI: 10.1016/j.bbmt.2009.07.015  0.36
2009 Subramaniyam V, Waller EK, Murrow JR, Manatunga A, Lonial S, Kasirajan K, Sutcliffe D, Harris W, Taylor WR, Alexander RW, Quyyumi AA. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. American Heart Journal. 158: 53-60.e1. PMID 19540392 DOI: 10.1016/j.ahj.2009.04.014  0.36
2009 Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults Autoimmunity Reviews. 9: 62-66. PMID 19293004 DOI: 10.1016/j.autrev.2009.03.006  0.36
2009 Akhtari M, Waller EK, Jaye DL, Lawson DH, Ibrahim R, Papadopoulos NE, Arellano ML. Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 322-4. PMID 19242368 DOI: 10.1097/CJI.0b013e31819aa40b  0.36
2009 Akhtari M, Langston AA, Waller EK, Gal AA. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients Bone Marrow Transplantation. 43: 155-158. PMID 18794871 DOI: 10.1038/bmt.2008.302  0.36
2008 Murali S, Winton E, Waller EK, Heffner LT, Lonial S, Flowers C, Kaufman J, Arellano M, Lechowicz MJ, Mann KP, Khoury HJ, Langston AA. Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone Marrow Transplantation. 42: 529-34. PMID 18622414 DOI: 10.1038/bmt.2008.201  0.36
2008 Lonial S, Torre C, David E, Harris W, Arellano M, Waller EK. Regulation of alloimmune responses by dendritic cell subsets Experimental Hematology. 36: 1309-1317. PMID 18620796 DOI: 10.1016/j.exphem.2008.04.021  0.36
2008 Hossain MS, Roback JD, Wang F, Waller EK. Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection. Journal of Immunology (Baltimore, Md. : 1950). 180: 6892-902. PMID 18453610  0.36
2008 Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, ... ... Waller EK, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 112: 426-34. PMID 18398065 DOI: 10.1182/blood-2007-12-128918  0.36
2008 Waller EK, Li JM. Donor dendritic cells dance the do-si-do in allogeneic transplantation Blood. 112: 3007-3008. DOI: 10.1182/blood-2008-08-171306  0.36
2007 Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy Oncologist. 12: 22-26. PMID 18039636 DOI: 10.1634/theoncologist.12-S2-22  0.36
2007 Waller EK. Hemorrhagic cystitis after hematopoietic stem cell transplantation: Much progress and many remaining issues Chinese Medical Journal. 120: 1671. PMID 17935667  0.36
2007 Ninan MJ, Flowers CR, Roback JD, Arellano ML, Waller EK. Posttransplant Thrombopoiesis Predicts Survival in Patients Undergoing Autologous Hematopoietic Progenitor Cell Transplantation Biology of Blood and Marrow Transplantation. 13: 895-904. PMID 17640593 DOI: 10.1016/j.bbmt.2007.04.001  0.36
2007 Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D. Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 844-52. PMID 17580263 DOI: 10.1016/j.bbmt.2007.03.011  0.36
2007 Santos EC, Sessions J, Hutcherson D, Flowers C, Langston A, Waller EK. Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation-A Similar Experience Biology of Blood and Marrow Transplantation. 13: 746-747. PMID 17531785 DOI: 10.1016/j.bbmt.2007.02.006  0.36
2007 Hammond AL, Waller EK, Finkelstein LB. CT2 - The clinical trials control tower: Overcoming barriers to opening oncology clinical trials [1] Journal of Clinical Oncology. 25: 1288. PMID 17401022 DOI: 10.1200/JCO.2006.10.3200  0.36
2007 Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion. 47: 629-35. PMID 17381621 DOI: 10.1111/j.1537-2995.2007.01164.x  0.36
2007 Hossain MS, Roback JD, Pollack BP, Jaye DL, Langston A, Waller EK. Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood. 109: 4548-56. PMID 17289817 DOI: 10.1182/blood-2006-04-017442  0.36
2007 Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience Biology of Blood and Marrow Transplantation. 13: 116-123. PMID 17222760 DOI: 10.1016/j.bbmt.2006.09.005  0.36
2007 Li JM, Waller EK. The yin and yang of adaptive immunity in allogeneic hematopoietic cell transplantation: donor antigen-presenting cells can either augment or inhibit donor T cell alloreactivity Advances in Experimental Medicine and Biology. 590: 69-87. PMID 17191378 DOI: 10.1007/978-0-387-34814-8_5  0.36
2006 Li JM, Gorechlad J, Larsen CP, Waller EK. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1239-49. PMID 17162205 DOI: 10.1016/j.bbmt.2006.08.038  0.36
2006 Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Lechowicz MJ, Waller EK. Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma Leukemia and Lymphoma. 47: 2155-2162. PMID 17071490 DOI: 10.1080/10428190600774923  0.36
2006 Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms Modern Pathology. 19: 1555-1562. PMID 16998465 DOI: 10.1038/modpathol.3800679  0.36
2006 Li JM, Giver CR, Waller EK. Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT Experimental Hematology. 34: 895-904. PMID 16797417 DOI: 10.1016/j.exphem.2006.03.008  0.36
2006 Brinker BT, Waller EK, Leong T, Heffner LT, Redei I, Langston AA, Lonial S. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer. 106: 2171-80. PMID 16598756 DOI: 10.1002/cncr.21852  0.36
2006 Waller EK. A tale of two T cells: Suppressor CD8 T cells recalled to life Blood. 107: 4203-4204. DOI: 10.1182/blood-2006-03-008391  0.36
2006 Waller EK. Dendritic cells get VIP treatment Blood. 107: 3423-3424. DOI: 10.1182/blood-2006-02-001974  0.36
2005 David E, Sun SY, Waller EK, Chen J, Khuri FR, Lonial S. The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT. Blood. 106: 4322-9. PMID 16118318 DOI: 10.1182/blood-2005-06-2584  0.36
2005 Chahroudi A, Chavan R, Kozyr N, Koyzr N, Waller EK, Silvestri G, Feinberg MB. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. Journal of Virology. 79: 10397-407. PMID 16051832 DOI: 10.1128/JVI.79.16.10397-10407.2005  0.36
2005 Hossain MS, Roback JD, Lezhava L, Hillyer CD, Waller EK. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 11: 169-180. PMID 15744235 DOI: 10.1016/j.bbmt.2004.12.332  0.36
2005 Jabs A, Moncada GA, Nichols CE, Waller EK, Wilcox JN. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue Journal of Vascular Research. 42: 174-180. DOI: 10.1159/000084406  0.36
2004 Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products Biology of Blood and Marrow Transplantation. 10: 848-957. PMID 15570253 DOI: 10.1016/j.bbmt.2004.07.008  0.36
2004 Waller EK, Giver CR, Rosenthal H, Somani J, Langston AA, Lonial S, Roback JD, Li JM, Hossain MS, Redei I. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood Cells, Molecules & Diseases. 33: 233-7. PMID 15528137 DOI: 10.1016/j.bcmd.2004.08.009  0.36
2004 Li JM, Waller EK. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 10: 540-551. PMID 15282532 DOI: 10.1016/j.bbmt.2004.05.007  0.36
2004 Giver CR, Li JM, Hossain MS, Lonial S, Waller EK. Reconstructing immunity after allogeneic transplantation. Immunologic Research. 29: 269-82. PMID 15181288 DOI: 10.1385/IR:29:1-3:269  0.36
2004 Waller EK. Cellular Immunotherapy and Cancer Seminars in Oncology. 31: 87-90. PMID 15124140  0.36
2004 Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients Bone Marrow Transplantation. 33: 543-548. PMID 14730342 DOI: 10.1038/sj.bmt.1704408  0.36
2003 Roback JD, Hossain MS, Lezhava L, Gorechlad JW, Alexander SA, Jaye DL, Mittelstaedt S, Talib S, Hearst JE, Hillyer CD, Waller EK. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. Journal of Immunology (Baltimore, Md. : 1950). 171: 6023-31. PMID 14634114 DOI: 10.4049/jimmunol.171.11.6023  0.36
2003 Giver CR, Montes RO, Mittelstaedt S, Li JM, Jaye DL, Lonial S, Boyer MW, Waller EK. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects Biology of Blood and Marrow Transplantation. 9: 616-632. PMID 14569558 DOI: 10.1016/S1083-8791(03)00229-5  0.36
2003 Lonial S, Waller EK, Simons JW, Heffner LT. Signal transduction and myeloma: new targets, new hope. Cancer Biology & Therapy. 2: 310-9. PMID 14508098 DOI: 10.4161/cbt.2.4.425  0.36
2003 Waller EK, Ernstoff MS. Modulation of antitumor immune responses by hematopoietic cytokines Cancer. 97: 1797-1809. PMID 12655538 DOI: 10.1002/cncr.11247  0.36
2003 Waller EK, Langston AA, Lonial S, Cherry J, Somani J, Allen AJ, Rosenthal H, Redei I. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation Biology of Blood and Marrow Transplantation. 9: 460-471. DOI: 10.1016/S1083-8791(03)00127-7  0.36
2002 Jurickova I, Waller EK, Yeager AM, Boyer MW. Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia Bone Marrow Transplantation. 30: 687-697. PMID 12420208 DOI: 10.1038/sj.bmt.1703718  0.36
2002 Redei I, Langston AA, Lonial S, Cherry JK, Allen AJ, Hamilton E, Jones M, Bartlett VM, Waller EK. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors. Bone Marrow Transplantation. 30: 335-40. PMID 12235516 DOI: 10.1038/sj.bmt.1703649  0.36
2002 Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK. The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation Experimental Hematology. 30: 1044-1050. PMID 12225796 DOI: 10.1016/S0301-472X(02)00878-0  0.36
2002 Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. The American Journal of Pathology. 160: 2145-55. PMID 12057918 DOI: 10.1016/S0002-9440(10)61163-7  0.36
2002 Shaw RN, Waller EK, Offermann MK. Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell line. Leukemia & Lymphoma. 43: 631-4. PMID 12002770 DOI: 10.1080/10428190290012173  0.36
2002 Kean LS, Durham MM, Adams AB, Hsu LL, Perry JR, Dillehay D, Pearson TC, Waller EK, Larsen CP, Archer DR. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation. Blood. 99: 1840-9. PMID 11861303 DOI: 10.1182/blood.V99.5.1840  0.36
2002 Waller EK, Rosenthal H, Sagar L. DC2 effect on survival following allogeneic bone marrow transplantation Oncology (Williston Park, N.Y.). 16: 19-26. PMID 11829279  0.36
2002 Langston AA, Redei I, Caliendo AM, Somani J, Hutcherson D, Lonial S, Bucur S, Cherry J, Allen A, Waller EK. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood. 99: 1085-8. PMID 11807018 DOI: 10.1182/blood.V99.3.1085  0.36
2002 Somani J, Lonial S, Rosenthal H, Resnick S, Kakhniashvili I, Waller EK. A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: Effect on cellular and humoral immune responses Vaccine. 21: 221-230.  0.36
2001 Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM. The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. Blood. 98: 3205-11. PMID 11719355 DOI: 10.1182/blood.V98.12.3205  0.36
2001 Adams AB, Durham MM, Kean L, Shirasugi N, Ha J, Williams MA, Rees PA, Cheung MC, Mittelstaedt S, Bingaman AW, Archer DR, Pearson TC, Waller EK, Larsen CP. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. Journal of Immunology (Baltimore, Md. : 1950). 167: 1103-11. PMID 11441122  0.36
2001 Waller EK, Rosenthal H, Jones TW, Peel J, Lonial S, Langston A, Redei I, Jurickova I, Boyer MW. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood. 97: 2948-56. PMID 11342416 DOI: 10.1182/blood.V97.10.2948  0.36
2001 Lonial S, Bomberger C, Waller EK. Changes in the pattern of TCR Vβ repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans British Journal of Haematology. 113: 224-230. PMID 11328305 DOI: 10.1046/j.1365-2141.2001.02697.x  0.36
2000 Lopez RD, Waller EK, Lu PH, Negrin RS. CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells Cancer Immunology, Immunotherapy. 49: 629-640. PMID 11258789  0.36
2000 Lopez RD, Xu S, Guo B, Negrin RS, Waller EK. CD2-mediated IL-12-dependent signals render human γδ-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: Implications for the development of adoptive immunotherapy strategies Blood. 96: 3827-3837. PMID 11090067  0.36
2000 Waller EK, Boyer M. New strategies in allogeneic stem cell transplantation: Immunotherapy using irradiated allogeneic T cells Bone Marrow Transplantation. 25. PMID 10933181 DOI: 10.1038/sj.bmt.1702347  0.36
2000 Lonial S, Jones TW, Devine S, Winton EF, Heffner LT, Smith KJ, Yeager AM, Waller EK. High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma. Leukemia & Lymphoma. 36: 497-502. PMID 10784394 DOI: 10.3109/10428190009148397  0.36
2000 Boyer MW, Waller EK, Bray RA, Unangst T, Johnson TS, Phillips C, Jurickova I, Winton EF, Yeager AM. Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells Leukemia. 14: 412-418. PMID 10720135  0.36
2000 Sonnier SA, Waller EK. Increased risk of thrombotic microangiopathy associated with high levels of tacrolimus in the post-transplant period Blood. 96.  0.36
2000 Roback JD, Mittelstaedt S, Hillyer CD, Waller EK. Adoptive immunotherapy with fludarabine-treated cytomegalovirus primed donor splenocytes following mhc mis-matched allogeneic bone marrow transplantation in mice Blood. 96.  0.36
2000 Mittelstaedt SJ, Montes RO, Boyer MW, Waller EK. Fludarabine treated donor lymphocytes enhance immune reconstitution without gvhd in allogeneic bone marrow transplantation Blood. 96.  0.36
2000 Langston A, Jones TW, Rosenthal H, Redei I, Lonial S, Waller EK. Chronic GVHD (cGVHD) after matched sibling BMT is predicted by the number of transplanted donor NK-like T cells Blood. 96.  0.36
2000 Redei I, Längsten AA, Cherry JK, Hamilton ES, Jones ML, Waller EK. Effective T cell depletion of G-CSF mobilized haploidentical PBSC graft with combined positive/ negative immunomagnetic selection using isolex 300i system version 2.5 Blood. 96.  0.36
2000 Waller EK, Längsten AA, Bucur S, Lonial S, Cherry J, Feinstein B, Redei I. Sequential CD34+ and CD3+ allogeneic cell transplants in patients with poor risk hematologic malignancies Blood. 96.  0.36
2000 Amelia Längsten I, Redei, Bucur S, Cherry J, Alien A, Thourani J, Teagarden D, Mossavi-Sai S, Hutcherson D, Waller EK. Acyclovir (acv)-resistant herpes simplex virus (hsv) after t- and b-cell depleted haploidentical stem cell transplantation (sct) Blood. 96.  0.36
1999 Waller EK, Barlett N, Chen CH, Mujic V, Sussman H, Toepker S, Grenier K. Variations in the content of CD34+ cells in the peripheral blood of cancer patients receiving out-patient chemotherapy Cytotherapy. 1: 21-29. PMID 19746646  0.36
1999 Ship AM, Waller EK. Clinical use of irradiated donor lymphocytes in bone marrow transplantation Cancer Treatment and Research. 101: 267-282. PMID 10800653  0.36
1999 Lonial S, Bilodeau PA, Langston AA, Lewis C, Mossavi-Sai S, Holden JT, Waller EK. Acquired amegakaryocytic thrombocytopenia treated with allogeneic: BMT: A case report and review of the literature Bone Marrow Transplantation. 24: 1337-1341. PMID 10627644  0.36
1999 Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease Blood. 94: 3222-3233. PMID 10556211  0.36
1999 Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells Journal of Biological Chemistry. 274: 19587-19592. PMID 10391893 DOI: 10.1074/jbc.274.28.19587  0.36
1999 Waller EK. Heterogeneity of bone marrow stromal cells: Growth properties and cytokine production by CD34+ and CD34- stromal sub-sets Hematology. 4: 47-58.  0.36
1998 Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor Blood. 91: 4427-4433. PMID 9616135  0.36
1998 Bomberger C, Singh-Jairam M, Rodey G, Guerriero A, Yeager AM, Fleming WH, Holland HK, Waller EK. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood. 91: 2588-600. PMID 9516161  0.36
1998 Lopez RD, Poloso N, Negrin RS, Xu S, Waller EK. Engagement of CD2/LFA-2 on activated human peripheral blood T cells results in an IL-12-dependent resistance to Activation-Induced Cell Death (AICD) in γδ T cells Faseb Journal. 12.  0.36
1998 Zeder K, Waller EK, Redei I, Gerard Connaghan D, Fleming WH, Geller RB, Heffner LT, Hillyer CD, Holden J, Holland K, Jones W, Mccollum J, Mogul M, Phillips C, Rodey G, et al. Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation Cancer Research Therapy and Control. 5: 221-228.  0.36
1997 Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning Blood. 90: 5013-5021. PMID 9389721  0.36
1997 Guerriero A, Worford L, Holland HK, Guo GR, Sheehan K, Waller EK. Thrombopoietin is synthesized by bone marrow stromal cells. Blood. 90: 3444-55. PMID 9345028  0.36
1997 Geller RB, Devine SM, O'Toole K, Persons L, Keller J, Mauer D, Holland HK, Dix SP, Piotti M, Redei I, Connaghan G, Heffner LT, Hillyer CD, Waller EK, Winton EF, et al. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation Bone Marrow Transplantation. 20: 219-225. PMID 9257890  0.36
1997 Redei I, Waller EK, Holland HK, Devine SM, Wingard JR. Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions Bone Marrow Transplantation. 19: 175-177. PMID 9116616  0.36
1997 Holland HK, Brav RA, Otoole K, Holden JT, Connaghan PO, Heffiier LT, Waller EK, Winton EF, Yeager AM. Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS) Experimental Hematology. 25: 905.  0.36
1997 Waller EK, Worford LJ, Lynn M, Winton EF, Bray RA, Jones W, Rosenthal H, McCollum J, Holland HK, Yeager AM. Platelet recovery following autologous bone marrow transplantation correlates with the content of cd34+, cd38- cells in the marrow graft Experimental Hematology. 25: 898.  0.36
1996 Turner CW, Yeager AM, Waller EK, Wingard JR, Fleming WH. Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice. Blood. 87: 3237-44. PMID 8605339  0.36
1996 Waller EK. Irradiated allogene1c donor lymphocytes have an antileukemic effect in mice without producing graft vs. host disease Experimental Hematology. 24: 1092.  0.36
1995 Waller EK, Huang S, Terstappen L. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development Blood. 86: 710-718. PMID 7541673  0.36
1995 Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen L. The "common stem cell" hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors Blood. 85: 2422-2435. PMID 7537114  0.36
1994 Sen-Majumdar A, Weissman IL, Hansteen G, Marian J, Waller EK, Lieberman M. Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor Vβ gene products Journal of Virology. 68: 1165-1172. PMID 8289345  0.36
1994 Wilder RB, McGann JK, Sutherland WR, Waller EK, Minchinton AI, Goris ML, Knox SJ. The hypoxic cytotoxin sr 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts International Journal of Radiation Oncology, Biology, Physics. 28: 119-126. PMID 8270432 DOI: 10.1016/0360-3016(94)90149-X  0.36
1993 Kraft DL, Weissman IL, Waller EK. Differentiation of CD3-4-8- human fetal thymocytes in vivo: Characterization of a CD3- 4+ 8- intermediate Journal of Experimental Medicine. 178: 265-277. PMID 8315382  0.36
1993 Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 74: 833-43. PMID 8104101 DOI: 10.1016/0092-8674(93)90463-Z  0.36
1993 Waller EK, Ziemianska M, Bangs CD, Cleary M, Weissman I, Kamel OW. Characterization of posttransplant lymphomas that express T-cell-associated markers: Immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice Blood. 82: 247-261. PMID 8100721  0.36
1992 Lieberman M, Hansteen GA, Waller EK, Weissman IL, Sen-Majumdar A. Unexpected effects of the severe combined immunodeficiency mutation on murine lymphomagenesis Journal of Experimental Medicine. 176: 399-405. PMID 1500852 DOI: 10.1084/jem.176.2.399  0.36
1992 Waller EK, Sen-Majumdar A, Kamel OW, Hansteen GA, Schick MR, Weissman IL. Human T-cell development in SCID-hu mice: Staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy Blood. 80: 3144-3156. PMID 1467521  0.36
1991 Waller EK, Kamel OW, Cleary ML, Majumdar AS, Schick MR, Lieberman M, Weissman IL. Growth of primary T-cell non-Hodgkin's lymphomata in SCID-hu mice: Requirement for a human lymphoid microenvironment Blood. 78: 2650-2665. PMID 1824259  0.36
1986 Hettle JA, Waller EK, Fritz IB. Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells Biology of Reproduction. 34: 895-904. PMID 3730484  0.36
1985 Waller EK, Schleuning WD. Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis Journal of Biological Chemistry. 260: 6354-6360. PMID 4039726  0.36
1985 Rajput B, Degen SF, Reich E, Waller EK, Axelrod J, Eddy RL, Shows TB. Chromosomal locations of human tissue plasminogen activator and urokinase genes. Science (New York, N.Y.). 230: 672-4. PMID 3840278 DOI: 10.1126/science.3840278  0.36
1985 Fisher R, Waller EK, Grossi G, Thompson D, Tizard R, Schleuning WD. Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region Journal of Biological Chemistry. 260: 11223-11230. PMID 3161893  0.36
1983 Waller EK, Schleuning WD, Reich E. Complex-formation and inhibition of urokinase by blood plasma proteins Biochemical Journal. 215: 123-131. PMID 6194790  0.36
Show low-probability matches.